Unknown

Dataset Information

0

The structure of human GALNS reveals the molecular basis for mucopolysaccharidosis IV A.


ABSTRACT: Lysosomal enzymes catalyze the breakdown of macromolecules in the cell. In humans, loss of activity of a lysosomal enzyme leads to an inherited metabolic defect known as a lysosomal storage disorder. The human lysosomal enzyme galactosamine-6-sulfatase (GALNS, also known as N-acetylgalactosamine-6-sulfatase and GalN6S; E.C. 3.1.6.4) is deficient in patients with the lysosomal storage disease mucopolysaccharidosis IV A (also known as MPS IV A and Morquio A). Here, we report the three-dimensional structure of human GALNS, determined by X-ray crystallography at 2.2Å resolution. The structure reveals a catalytic gem diol nucleophile derived from modification of a cysteine side chain. The active site of GALNS is a large, positively charged trench suitable for binding polyanionic substrates such as keratan sulfate and chondroitin-6-sulfate. Enzymatic assays on the insect-cell-expressed human GALNS indicate activity against synthetic substrates and inhibition by both substrate and product. Mapping 120 MPS IV A missense mutations onto the structure reveals that a majority of mutations affect the hydrophobic core of the structure, indicating that most MPS IV A cases result from misfolding of GALNS. Comparison of the structure of GALNS to paralogous sulfatases shows a wide variety of active-site geometries in the family but strict conservation of the catalytic machinery. Overall, the structure and the known mutations establish the molecular basis for MPS IV A and for the larger MPS family of diseases.

SUBMITTER: Rivera-Colon Y 

PROVIDER: S-EPMC3472114 | biostudies-literature | 2012 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

The structure of human GALNS reveals the molecular basis for mucopolysaccharidosis IV A.

Rivera-Colón Yadilette Y   Schutsky Emily K EK   Kita Adriana Z AZ   Garman Scott C SC  

Journal of molecular biology 20120829 5


Lysosomal enzymes catalyze the breakdown of macromolecules in the cell. In humans, loss of activity of a lysosomal enzyme leads to an inherited metabolic defect known as a lysosomal storage disorder. The human lysosomal enzyme galactosamine-6-sulfatase (GALNS, also known as N-acetylgalactosamine-6-sulfatase and GalN6S; E.C. 3.1.6.4) is deficient in patients with the lysosomal storage disease mucopolysaccharidosis IV A (also known as MPS IV A and Morquio A). Here, we report the three-dimensional  ...[more]

Similar Datasets

| S-EPMC9291100 | biostudies-literature
| S-EPMC4203673 | biostudies-literature
| S-EPMC6072674 | biostudies-literature
| S-EPMC452294 | biostudies-other
| S-EPMC4526736 | biostudies-literature
| S-EPMC10042821 | biostudies-literature
| S-EPMC9602411 | biostudies-literature
| S-EPMC2648862 | biostudies-literature
| S-EPMC6511015 | biostudies-literature
| S-EPMC1538984 | biostudies-literature